These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 16437504)

  • 1. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
    Playford EG; Webster AC; Sorrell TC; Craig JC
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004920. PubMed ID: 16437504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
    Playford EG; Webster AC; Sorrell TC; Craig JC
    J Antimicrob Chemother; 2006 Apr; 57(4):628-38. PubMed ID: 16459344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
    Cortegiani A; Russotto V; Maggiore A; Attanasio M; Naro AR; Raineri SM; Giarratano A
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004920. PubMed ID: 26772902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal agents for preventing fungal infections in solid organ transplant recipients.
    Playford EG; Webster AC; Sorell TC; Craig JC
    Cochrane Database Syst Rev; 2004; (3):CD004291. PubMed ID: 15266524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
    Clerihew L; Austin N; McGuire W
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003850. PubMed ID: 17943803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections.
    Blyth CC; Hale K; Palasanthiran P; O'Brien T; Bennett MH
    Cochrane Database Syst Rev; 2010 Feb; 2010(2):CD006343. PubMed ID: 20166083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
    Austin N; McGuire W
    Cochrane Database Syst Rev; 2013 Apr; (4):CD003850. PubMed ID: 23633315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
    Cleminson J; Austin N; McGuire W
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003850. PubMed ID: 26497056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
    Austin N; Darlow BA; McGuire W
    Cochrane Database Syst Rev; 2013 Mar; (3):CD003478. PubMed ID: 23543519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
    Austin N; Cleminson J; Darlow BA; McGuire W
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003478. PubMed ID: 26497202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
    Austin N; Darlow BA; McGuire W
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003478. PubMed ID: 19821309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nystatin prophylaxis and treatment in severely immunodepressed patients.
    Gøtzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2002; (4):CD002033. PubMed ID: 12519566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants.
    McGuire W; Clerihew L; Austin N
    Cochrane Database Syst Rev; 2003; (1):CD003850. PubMed ID: 12535489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
    Jørgensen KJ; Gøtzsche PC; Dalbøge CS; Johansen HK
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD004707. PubMed ID: 24563222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine versus selective antifungal administration for control of fungal infections in patients with cancer.
    Gotzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2000; (4):CD000026. PubMed ID: 11034669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nystatin prophylaxis and treatment in severely immunodepressed patients.
    Gøtzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002033. PubMed ID: 25188770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants.
    McGuire W; Clerihew L; Austin N
    Cochrane Database Syst Rev; 2004; (1):CD003850. PubMed ID: 14974040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of topical nonabsorbable gastrointestinal antifungal prophylaxis to prevent fungal infections in critically ill immunocompetent patients: a meta-analysis.
    Ho KM; Rochford SA; John G
    Crit Care Med; 2005 Oct; 33(10):2383-92. PubMed ID: 16215396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine versus selective antifungal administration for control of fungal infections in patients with cancer.
    Gotzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2002; (2):CD000026. PubMed ID: 12076377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.